Community-Acquired Bacterial Pneumonia

Kendig's Disorders of the Respiratory Tract in Children

Volumn , Issue , 2006, Pages 441-452

  Stein, Renato T ^a   Marostica, Paulo J C ^b,c  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882564051     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-3695-5.50031-6     Document Type: Chapter

References (42)

1. Clements H, Stephenson T, Gabriel V, Harrison T, Millar M, Smyth A, Tong W, Linton CJ Rationalised prescribing for community-acquired pneumonia. A closed loop audit. Arch Dis Child 2000, 83:320-324.
2. McCracken GH Etiology and treatment of pneumonia. Pediatr Infect Dis J 2000, 19:373-377.
3. Jadavji T, Law B, Lebel MH, Kennedy WA, Gold R, Wang EEL A practical guide for the diagnosis and treatment of pediatric pneumonia. Can Med Assoc J 1997, 156:S703-S711.
4. Mulholland K Magnitude of the problem of childhood pneumonia. Lancet 1999, 354:590-592.
5. Wubbel L, Muniz L, Ahmed A, Trujillo M, Carubelli C, McCoig C, Abramo T, Leinonen M, McCracken GH Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999, 18:98-104.
6. Mulholland EK, Adegbola RA The Gambian Haemophilus influenzae type b vaccine trial. What does it tell us about the burden of Haemophilus influenzae type B disease?. Pediatr Infect Dis J 1998, 17:S123-S125.
7. Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, Kallinen S, Stén M, Tarkiainen A, Rönnberg PR, Kleemola M, Mäkelä PH, Leinonen M Etiology of childhood pneumonia. Serologic results of a prospective, population-based study. Pediatr Infect Dis J 1998, 17:986-991.
8. Toikka P, Juvén T, Virkki R, Leinonen M, Mertsola J, Ruuskanen O Streptococcus pneumoniae and Mycoplasma pneumoniae coinfection in community-acquired pneumonia. Arch Dis Child 2000, 83:413-414.
9. Principi N, Esposito S, Blasi F, Allegra L, the Mowgli Study Group Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 2001, 32:1281-1289.
10. Esposito S, Bosis S, Cavagna R, Faelli N, Begliatti E, Marchisio P, Blasi F, Bianchi C, Principi N Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia. Clin Infect Dis 2002, 35:1345-1352.
11. Nelson JD Community-acquired pneumonia in children. Guidelines for treatment. Pediatr Infect Dis J 2000, 19:251-253.
12. McIntosh K Community-acquired pneumonia in children. N Engl J Med 2002, 346:429-437.
13. Ruuskanen O, Mettsola J Childhood community-acquired pneumonia. Semin Respir Infect 1999, 14:163-172.
14. Coote NMA, Craig J, Heath PT, McKenzie AS, Saul P, Smyth R, Thomson AH, for Pneumonia in Childhood Guideline Development Group of BTS Standards of Care BTS guidelines for the management of community-acquired pneumonia in childhood. Thorax 2002, 57(1):i1-i24.
15. Russell G Community-acquired pneumonia. Arch Dis Child 2001, 85:445-446.
16. Lynch T, Platt R, Gouin S, Larson C, Patenaude Y Can we predict which children with clinically suspected pneumonia will have the presence of focal infiltrates on chest radiographs?. Pediatrics 2004, 113:e186-e189.
17. Korppi M, Heiskanen-Kosma T, Leinonen M White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur Respir J 1997, 10:1125-1129.
18. Toikka P, Irjala K, Juven T, Virkki R, Mertsola J, Leinonen M, Ruuskanen O Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000, 19:598-602.
19. Vuori-Holopainen E, Salo E, Saxén H, Hedman K, Hyypiä T, Lahdenperä R, Leinonen M, Tarkka E, Vaara M, Peltola H Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis 2002, 34:583-590.
20. Zar HJ, Tannenbaum E, Hansio D, Hussey G Sputum induction as a diagnostic tool for community-acquired pneumonia in infants and young children from a high HIV prevalence area. Pediatr Pulmonol 2003, 36:58-62.
21. Bradley JS Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines. Pediatr Infect Dis J 2002, 21:592-598.
22. Zhao GM, Black S, Shinefield H, Wang CQ, Zhang YH, Lin YZ, Lu JL, Guo YF, Jiang QW Serotype distribution and antimicrobial resistance patterns in Streptococcus pneumoniae isolates from hospitalized pediatric patients with respiratory infections in Shangai, China. Pediatr Infect Dis J 2003, 22:739-742.
23. Juvén T, Mertsola J, Waris M, Leinonen M, Meurman O, Roivainen M, Eskola J, Saikku P, Ruuskanen O Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000, 19:293-298.
24. Bachur R, Perry H, Harper MB Occult pneumonias. Empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med 1999, 33:166-173.
25. Swingler GH, Hussey GD, Zwarenstein M Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children. Lancet 1998, 351:404-408.
26. Kogan R, Martiínez MA, Rubilar L, Payá E, Quevedo I, Puppo H, Girardi G, Castro-Rodriguez JA Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. Pediatr Pulmonol 2003, 35:91-98.
27. Virkki R, Juven T, Rikalainen H, Svedström E, Mertsola J, Ruuskanen O Differentiation of bacterial and viral pneumonia in children. Thorax 2002, 57:438-441.
28. Eijkman-Winkler Centre for Medical Microbiology, Infectious Diseases and Inflammation. Available at. http://www.ewi.med.uu.nl/ewi_en/.
29. Australian Government, Department of Health and Ageing. Available at. http://www.health.gov.au/internet/wcms/Publishing.nsf/Content/Communicab le+Diseases+Australia-1.
30. European Antimicrobial Resistance Surveillance System. Available at. http://www.earss.rivm.nl.
31. Deeks SL, Palacio R, Ruvinsky R, Kertesz DA, Hortal M, Rossi A, Spika JS, Fabio JLD, The Streptococcus pneumoniae Working Group Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. Pediatrics 1999, 103:409-413.
32. Tan TQ, Mason EO, Wald ER, Barson WJ, Schutze GE, Bradley JS, Givner LB, Yogev R, Kim KS, Kaplan SL Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 2002, 110:1-6.
33. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, Plouffe JF, Räkowsky A, Schuchat A, Whitney CG, the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group Management of community-acquired pneumonia in the era of pneumococcal resistance. Arch Intern Med 2000, 160:1399-1408.
34. Shann F, Harta K, Thomas D Acute lower respiratory tract infections in children. Possible criteria for selection of patients for antibiotic therapy and hospital admission. Bull WHO 1984, 62:749-753.
35. Campbell H, Byass P, Forgie JM, O'Neill KP, Lloyd EN, Greenwood BM Trial of cotrimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children. Lancet 1988, 2:1182-1184.
36. Wallis C, Prasad A Who needs chest physiotherapy? Moving from anecdote to evidence. Arch Dis Child 1999, 80:393-397.
37. Ficnar B, Huzjak N, Oreskovic K, Matrapazovski M, Klinar I Azithromycin: 3-day versus 5-day course in the treatment of respiratory tract infections in children. Croatian Azithromycin Study Group. J Chemother 1997, 9:38-43.
38. Vuori-Holopainen E, Peltola H, Kallio MJT, for the SE-TU Study Group Narrow versus broad-spectrum parenteral antimicrobials against common infections of childhood. A prospective and randomized comparison between penicillin and cefuroxime. Eur J Pediatr 2000, 159:878-884.
39. Tsarouhas N, Shaw KN, Hodinka RL, Bell LM Effectiveness of intramuscular penicillin versus oral amoxicillin in the early treatment of outpatient pediatric pneumonia. Pediatr Emerg Care 1998, 14:338-341.
40. Chumpa A, Bachur RG, Harper MB Bacteremia-associated pneumococcal pneumonia and benefit of initial parenteral antimicrobial therapy. Pediatr Infect Dis J 1999, 18:1081-1085.
41. Shah SS, Alpern ER, Zwerling L, McGowan KL, Bell LM Risk of bacteremia in young children with pneumonia treated as outpatient. Arch Pediatr Adolesc Med 2003, 157:389-392.
42. Pakistan Multicentre Amoxicillin Short Course Therapy (MASCOT) Pneumonia Study Group Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia. A multicentre double-blind trial. Lancet 2002, 360:35-41.